These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30157160)
1. Management of Bacterial Conjunctivitis in Children-Preferred Practice Pattern in Northern Greece. Mataftsi A; Kokkali S; Papagianni E; Tsonona V; Mavridou E; Ziakas N; Haidich AB Eye Contact Lens; 2018 Sep; 44 Suppl 1():S373-S374. PubMed ID: 30157160 [No Abstract] [Full Text] [Related]
2. Chloramphenicol Eye Drops: An Old Dog in a New House. Andaluz-Scher L; Medow NB Ophthalmology; 2020 Oct; 127(10):1289-1291. PubMed ID: 32739192 [No Abstract] [Full Text] [Related]
3. Primary meningococcal conjunctivitis: an unusual case of transmission by saliva. Dryden AW; Rana M; Pandey P Digit J Ophthalmol; 2016; 22(1):25-7. PubMed ID: 27330479 [TBL] [Abstract][Full Text] [Related]
6. Conjunctivitis in children. Normann EK Lancet; 2005 Jul 2-8; 366(9479):6-7. PubMed ID: 15993210 [No Abstract] [Full Text] [Related]
7. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid. Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576 [TBL] [Abstract][Full Text] [Related]
8. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000. Baum J; Barza M Cornea; 2000 Sep; 19(5):659-72. PubMed ID: 11009318 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis. Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F; Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection. Vyas U; Desai T; Shah C J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674 [TBL] [Abstract][Full Text] [Related]
11. Conjunctivitis due to Neisseria sicca: a case report. Eser I; Akcali A; Tatman-Otkun M; Taskiran-Comez A Indian J Ophthalmol; 2014 Mar; 62(3):350-2. PubMed ID: 23552355 [TBL] [Abstract][Full Text] [Related]
12. Resistant Infantile Bacterial Conjunctivitis in Egypt: A Microbiology Study. Hashish AA; Elbakary MA; Allam WA J Pediatr Ophthalmol Strabismus; 2018 Mar; 55(2):135-139. PubMed ID: 29131910 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials. Comstock TL; Paterno MR; Usner DW; Pichichero ME Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747 [TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447 [TBL] [Abstract][Full Text] [Related]
18. Conjunctivitis Preferred Practice Pattern®. Varu DM; Rhee MK; Akpek EK; Amescua G; Farid M; Garcia-Ferrer FJ; Lin A; Musch DC; Mah FS; Dunn SP; Ophthalmology; 2019 Jan; 126(1):P94-P169. PubMed ID: 30366797 [No Abstract] [Full Text] [Related]
19. Ophthalmic ciprofloxacin. Med Lett Drugs Ther; 1991 May; 33(845):52-3. PubMed ID: 2030657 [No Abstract] [Full Text] [Related]
20. [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]. Zhang M; Hu Y; Chen F Yan Ke Xue Bao; 2000 Jun; 16(2):146-8. PubMed ID: 12579927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]